Treatment of CD 20+ Hodgkin Lymphoma (Lymphocyte Predominant) with Monoclonal Antibody Rituximab after First-Line Treatment Is Effective and Might Improve the Outcome
| Autor: | Genadieva-Stavrik, Sonja, Pivkova, Alexandra *, Ivkovski, Ljube *, Cevreska, Lidija * |
|---|---|
| Zdroj: | In Blood 16 November 2008 112(11):5007-5007 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|